Experienced scientist with doctoral degree in biochemistry with more than
* ***** ** ********** ********** (2 years bio-pharmaceutical industry)
working on originator and bio-similar molecules in areas of protein
formulation, drug product process development, bio-analytical & biophysical
methods and primary container development strategy for proteins.
. Expertise in analytical chemistry, pharmaceutics and able to diagnose
the problem and lead a team to generate pragmatic solutions. Ability
to independently generate precise, protocol, technical reports,
summaries and memos as well as follows protocols, documents results
and reviews summary reports.
. Involved in identifying and developing drug product manufacturing
processes including bulk protein freeze/thaw, liquid mixing, sterile
filtration, container filling, visual inspection, as well as
transportation / cold chain management of parenterals.
. Highly skilled in various optical microscopic techniques, particle
size distribution and particle characterization (Optical
Stereomicroscopic particle analysis, SEM/EDS, AccuSizer780, Low volume
HIAC, FPIA, NTA, Archimedes, Micro Flow Imaging as well as Visual/
enhanced visual inspection methods. Working experience using
Spectroscopic techniques including IR/FTIR.
. Independently developed sub-visible particle methods for analysis of
protein biopharmaceuticals. Micro-flow imaging method currently being
used for stability testing. Drafted study protocol and lead analyst
training for enhanced visual testing of Drug Product.
. Design and Execute FPLC protein purification experiments
(AKTA/Unicorn) and apply the results to process development and
optimization.
. Bio-analytical method development and validations (HPLC, UPLC and GC)
for release, in process, and stability of API, excipients as well as
drug products (small molecule and proteins/ peptide). Purification and
characterization of related substances/ impurities in DS and drug
product. Performs pre-validation studies, validations and
robustness/optimization for analytical methods.
. Responsible for the technology transfer of processes to domestic and
international sites, including the identification, design, and
execution of at-scale process studies, as well as developing and
ensuring adherence to project schedules.
. Cellular assays to measure viability, proliferation, and apoptosis
(cell based assay, enzymatic assay, aseptic and cell cultures both
suspension and attached). Working experience in patch clamping, ELISA,
SDS-PAGE, western blotting and in conducting cell signaling pathway
studies.
. Several years of experience working in high performance teams on
commercialization of pipeline molecules in addition to leading a sub
group of analyst(s) for emphasizing quality control, laboratory
operation, project management, method transfer, product development
and document writing.
Work Experience Summary:
Contract Scientist: August, 2011 to Sept 2013
Hospira, Inc: Global Pharma Biologics R&D, Lake Forest IL-60045
Significant contributions in biophysical characterization of proteins and
protein formulations, method development, transfer protocols/ SOP auditing
GMP/GLP/GDP work.
Major Contributions:
. Maintains laboratory instrumentation and systems according to cGMP
requirement/
. Bio-similarity and comparability studies on therapeutic protein
formulations.
. Developed various methods for early detection and identification of
glass lamellae in drug products using various techniques including
Micro Flow Imaging by applying morphological filters for separation of
sub population of glass particles/ silicon oil from other particles.
. Developed methods for characterization of protein aggregates/sub
visible particles distribution both at the level of sub micron (<1?m)
using NanoSight and Archimedes and micron (2-25?m) using AccuSizer,
Low Volume HIAC and Micro Flow Imaging.
. Conducted shear stress and membrane filtration, filter flush and
needle flush studies on protein drug product.
. Involved in investigations of method performance, and OOS and OOT
results generated in Global Biologics R&D.
. Developed and execute protocol for analyst training/ qualification for
visual/ enhanced visual inspection.
. Characterized visible/ sub visible particle in protein drug
formulations using various orthogonal methods/ approaches.
. Glass vial durability testing and glass de-lamination mitigation
strategies.
. Identified and developed drug product manufacturing processes
including bulk protein freeze/thaw, liquid mixing, sterile filtration,
container filling, visual inspection, as well as transportation / cold
chain management of parenterals.
Stability database evaluation and assessment:
. Stability testing of protein drug product as well as maintain a
compliant, audit ready LIMS stability data base. Perform data entry
and verification in LIMS system.
Education:
. MS in Biochemistry, University of Hisar Haryana-125004 (CCS HAU-
Hisar, India)
o MS- Dissertation "Isolation, purification and characterization of
major proteins from a promising cultivar of Cicer arietium (Chickpea)
and determination of nutritional quality".
. BS Biology, University of Himachal Pardesh Shimla-05 (India).
. Planning, Implementation & Documentation for ISO 9000 Quality
Management System from Indian Institute of Quality Management Jaipur-
India.
. Six Sigma White Belt Certificate of Achievement (2013) from Aveta
Business Institute-USA.
Analytical Expertise:
Demonstrated skills and trouble shooting experience in the following
techniques/ Instrument Equipment: HPLC, UPLC (Empower) instruments
with a variety of detection systems, FPLC (AKTA/Unicorn), GC/MS,
Stereo-microscopy (Using Image-Pro) analysis of particles, NanoSight,
Archimedes analysis, Low Volume HIAC, AccuSizer 780, MFI, various
types of electrophoresis including SDS-PAGE, capillary
electrophoresis, western blotting, ELISA, radioimmunoassay (RIA),
spectroscopy (UV/VIS, fluorescence, or CD of bio-pharmaceutical
compound.
Technical Expertise:
. Protein purification and characterization using various biophysical
tools. Design and Execute FPLC protein purification experiments
(AKTA/Unicorn) and apply the results to process development and
optimization.
. Analytical method development and full validation (HPLC/GC) for API,
excipients as well as drug products (small molecule and proteins/
peptide drug products).
. Purification and characterization of related substances/ impurities in
DS and drug product.
. Characterized visible/ sub visible particle in protein Drug
formulations using various orthogonal methods/ approaches.
. Analyst training/ Qualification for Visual/ Enhanced visual
Inspection.
. Glass vial durability testing and Glass De-lamination mitigation
strategies.
. Lipid analysis.
. Proficiency in general laboratory techniques, in vitro and in vivo
sample preparation for quantification in biological matrices. Small
animal surgical procedures, ex-vivo culture of blood vessels and cell
culture techniques.
Software Knowledge:
. Trained on required Hospira lab software tools.
. Demonstrated working experience using Empower chromatography data
software, eLN software from Accerlys, Clarity, LIMS, NuGenesis SDMS,
Origin 8.0 and JMP software.
Professional References:
. Krishnan Sampath,
Associate Director, Process Development
Global Biologics R&D, Hospira, Inc
275 North Drive, Lake Forest IL 60045, Tel: 224-***-****, Cell: 224-
358-1606
Fax: 224-***-**** E-mail: ********.************@*******.***
. Catherine A. Srebalus Barnes, Ph.D
Senior Director Bio- analytical Sciences,
Global Biologics R&D, Hospira, Inc
275 North Drive, Lake Forest IL 60045, Tel: 224-***-****, Fax: 224-
212-7905, E-mail: *********.**************@*******.***
. Sanjay V. Kamat, Ph.D. MBA
Associate Director, DP Engineering & Technology Transfer
Global Biologics R&D Hospira, Inc
275 North Drive, Lake Forest IL 60045 Tel: 224-***-**** (P),
Cell:224-***-**** E-mail: ******.*****@*******.***